The Consumer Justice Foundation, a free online resource designed to provide consumers with information regarding how they should deal with large corporations that include pharmaceutical drug companies ...

The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a drug safety update for the anticonvulsant topiramate (Topamax, Janssen-Cilag ), which is now expressly contraindicated in ...

Topiramate (Topamax)—along with exercise and a reduced-calorie diet—can help lower weight and blood sugar in obese adults with type 2 diabetes, a Swedish trial reveals. Indicated for epilepsy and ...

June 11, 2008 — A drug already used to treat seizures and migraine headaches has once again been proven effective in curbing heavy drinking. The current study, published in the June 9 issue of the ...

How Does Topirmate for Weight Loss Work? Topiramate, also sold under the brand name Topamax, is a drug approved by the U.S. Food and Drug Administration (FDA) for epilepsy and migraines. It’s also ...

Topiramate (Topamax) 25 mg once daily, titrated to 300 mg/day in two divided doses for 14 weeks, was evaluated in a placebo-controlled randomized trial in 371 patients aged 18-65 years with alcohol ...

The anti-seizure drug topiramate (Topamax and generic) might cause cleft lips and palates in children born to women who take the medication while pregnant, according to a new warning from the Food and ...

The FDA notified healthcare professionals and patients that topiramate (Topamax; Ortho-McNeil) is now being placed in Pregnancy Category D after new human data showed an increased risk of development ...

New data suggest that the drug Topamax (topiramate) and its generic versions increase the risk for the birth defects cleft lip and cleft palate in babies born to women who use the medication during ...

Other research has suggested that it might suppress the nerves directly, thereby making them less likely to fire. In, Topamax received FDA approval for the prevention of migraines. Manufactured by ...

The Consumer Justice Foundation (CJF) comments on a new study (“Topiramate in the New Generation of Drugs: Efficacy in the Treatment of Alcoholic Patients,” ncbi.nlm.nih.gov) published by the ...